Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: bilateral pneumonia; exacerbation of chronic bronchitis; No diuresis; general condition had greatly deteriorated; confused, hypotonic; confused, hypotonic; This is a spontaneous report from a contactable physician downloaded from the WEB, the Regulatory Authority number is HU-OGYI-416521. This spontaneous, serious case was reported by a physician on 31May2021, concerning bilateral pneumonia after the administration of Comirnaty concentrate for dispersion for injection (30 micrograms of COVID-19 mRNA Vaccine, MAH: BioNTech Manufacturing GmbH/ Pfizer). On 23May2021, the 44-year-old female patient received the second dose of Comirnaty (COVID-19 mRNA Vaccine (nucleoside modified)/ Tozinameran) concentrate for dispersion for injection ( 1 dose (0.3 mL) contains 30 micrograms of COVID-19 mRNA Vaccine, intramuscularly, left arm, lot number: FA4598). First dose was given on 15Apr2021, batch number: EW4815). On 27May2021, the patient was transported to the hospital due to dyspnoea started a few days before, diarrhea complaints started 2 months before, and her general condition had greatly deteriorated. COVID-19 rapid test was negative. Due to superficial spontaneous respiration, non-invasive ventilation was started with mild sedation. The patient was confused, hypotonic, for which she received norepinephrine; she also had no diuresis. In the absence of compliance, the patient was intubated, ventilated, and given dobutamine. ECG showed wide QRS, heart rate was 30 / min, the patient was hypotonic. Tonogen (epinephrine) and atropine were given, but her heart rate did not change. Complete cardiopulmonary resuscitation was initiated, unsuccessfully. At 12:35, the patient died. According to the autopsy, the cause of death was bilateral pneumonia due to the exacerbation of chronic bronchitis. Medical history included unspecified cardiac operation when the patient was 3 years old, aortic valve replacement and mitral valve repair in //2017. The patient did not attend regular treatments. No further information is expected. Sender Comment: The patient died 4 days after the second dose of Comirnaty. The cause of death was bilateral pneumonia due to the exacerbation of chronic bronchitis. The causal relationship between the event and Comirnaty is considered unlikely. The case is serious due to fatal outcome. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Bilateral pneumonia; exacerbation of chronic bronchitis
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166